Francois Rochon’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$134M Sell
253,931
-2,150
-0.8% -$992K 4.52% 7
2026
Q1
$123M Sell
256,081
-7,239
-3% -$3.71M 4.5% 8
2025
Q4
$148M Buy
263,320
+1,518
+0.6% +$862K 4.93% 7
2025
Q3
$135M Buy
261,802
+47
+0% +$20.5K 4.56% 8
2025
Q2
$82.2M Buy
261,755
+9,818
+4% +$2.95M 2.82% 16
2025
Q1
$76.8M Buy
251,937
+17,650
+8% +$5.94M 2.83% 15
2024
Q4
$77.8M Buy
234,287
+7,215
+3% +$2.45M 2.85% 13
2024
Q3
$75.8M Buy
227,072
+38,978
+21% +$14.8M 2.88% 14
2024
Q2
$77.5M Buy
188,094
+2,862
+2% +$1.13M 3.27% 12
2024
Q1
$74.9M Buy
185,232
+27,568
+17% +$9.69M 3.04% 14
2023
Q4
$48.3M Buy
157,664
+153,904
+4,093% +$41.5M 2.27% 18
2023
Q3
$910K Buy
+3,760
New +$962K 0.05% 45

Other funds holding MEDP

Francois Rochon's MEDP Position: Q2 2026 in Review

Francois Rochon reduced its Medpace (MEDP) stake by 0.84% in Q2 2026, selling an estimated $992K and leaving 253,931 shares worth $134M. The position accounts for 4.52% of the portfolio, ranked #7.

Francois Rochon first reported a position in MEDP in Q3 2023 and has held it in 12 quarters since. The position peaked at $148M in Q4 2025. 693 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Francois Rochon held 253,931 shares of Medpace worth $134M as of Q2 2026.
  • Francois Rochon sold 2,150 Medpace shares in Q2 2026, an estimated $992K.
  • Medpace made up 4.52% of Francois Rochon's portfolio in Q2 2026, its #7 holding.
  • Francois Rochon first reported a position in Medpace in Q3 2023 and has held it in 12 quarters since.
  • Francois Rochon's Medpace position peaked at $148M in Q4 2025.
  • 693 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Giverny Capital's 13F filing for Q2 2026, filed 14 Aug 2026.